FR117M - Nouveau biguanide utilisable en thérapeutique. - Google Patents

Nouveau biguanide utilisable en thérapeutique.

Info

Publication number
FR117M
FR117M FR835240A FR835240A FR117M FR 117 M FR117 M FR 117M FR 835240 A FR835240 A FR 835240A FR 835240 A FR835240 A FR 835240A FR 117 M FR117 M FR 117M
Authority
FR
France
Prior art keywords
therapy
biguanide
new
new biguanide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR835240A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
BASF Schweiz AG
Original Assignee
Ciba Geigy AG
Ciba AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG, Ciba AG filed Critical Ciba Geigy AG
Priority to FR835240A priority Critical patent/FR117M/fr
Application granted granted Critical
Publication of FR117M publication Critical patent/FR117M/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/20—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
    • C07C279/24—Y being a hetero atom
    • C07C279/26—X and Y being nitrogen atoms, i.e. biguanides
    • C07C279/265—X and Y being nitrogen atoms, i.e. biguanides containing two or more biguanide groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/45—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups at least one of the singly-bound nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylaminosulfonamides
    • C07C311/47—Y being a hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/15—Six-membered rings
    • C07D285/16—Thiadiazines; Hydrogenated thiadiazines
    • C07D285/18—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines
    • C07D285/20—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems
    • C07D285/22—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D285/24—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with oxygen atoms directly attached to the ring sulfur atom
    • C07D285/26—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with oxygen atoms directly attached to the ring sulfur atom substituted in position 6 or 7 by sulfamoyl or substituted sulfamoyl radicals
    • C07D285/30—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with oxygen atoms directly attached to the ring sulfur atom substituted in position 6 or 7 by sulfamoyl or substituted sulfamoyl radicals with hydrocarbon radicals, substituted by hetero atoms, attached in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
FR835240A 1960-06-14 1960-08-08 Nouveau biguanide utilisable en thérapeutique. Expired FR117M (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR835240A FR117M (fr) 1960-06-14 1960-08-08 Nouveau biguanide utilisable en thérapeutique.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR829874A FR1295362A (fr) 1960-06-14 1960-06-14 Procédé de préparation de nouveaux biguanides, en particulier de composés du 4-biguanido-diphényle
FR835240A FR117M (fr) 1960-06-14 1960-08-08 Nouveau biguanide utilisable en thérapeutique.

Publications (1)

Publication Number Publication Date
FR117M true FR117M (fr) 1961-01-09

Family

ID=8733313

Family Applications (2)

Application Number Title Priority Date Filing Date
FR829874A Expired FR1295362A (fr) 1960-06-14 1960-06-14 Procédé de préparation de nouveaux biguanides, en particulier de composés du 4-biguanido-diphényle
FR835240A Expired FR117M (fr) 1960-06-14 1960-08-08 Nouveau biguanide utilisable en thérapeutique.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FR829874A Expired FR1295362A (fr) 1960-06-14 1960-06-14 Procédé de préparation de nouveaux biguanides, en particulier de composés du 4-biguanido-diphényle

Country Status (1)

Country Link
FR (2) FR1295362A (fr)

Also Published As

Publication number Publication date
FR1295362A (fr) 1962-06-08

Similar Documents

Publication Publication Date Title
FR302M (fr) Nouvelle m-butoxy-phénoxy-éthylamine utilisable en thérapeutique.
FR308M (fr) Nouvelle pyridyl-éthyl-guanidine utilisable en thérapeutique.
FR3377M (fr) Pommade utilisable en ophtalmologie.
DK112436B (da) Stable- og læsseapparat.
FR117M (fr) Nouveau biguanide utilisable en thérapeutique.
FR1898M (fr) Nouvelle substance utilisable en thérapeutique.
CH388699A (de) Biegungsfreie Walze
CH385435A (de) Tasche mit Verschluss
BE608155A (nl) Rekeninrichting.
FR164M (fr) Nouvelle hydrazine utilisable en thérapeutique.
FR1233212A (fr) Cystoscope utilisable en pédiatrie
BE607144A (fr) Empileuse perfectionnée
BE596272A (fr) Nouvelle substance utilisable en thérapeutique.
FR350M (fr) Nouvel antibiotique lankavamycine utilisable en thérapeutique.
FR221M (fr) Nouvelle guanidine utilisable en thérapeutique.
FR353M (fr) Nouvelle quinoléine utilisable en thérapeutique.
CH379875A (fr) Contre-pointe
FR115M (fr) Nouveau sulfonamide utilisable en thérapeutique.
FR1029M (fr) Nouveau 17α-isobutyl-androstane-3β,17β-diol utilisable en thérapeutique.
FR3174M (fr) Nouvel δ-3β17β-dihydroxy-7α17α-diméthyl-19-nor-androstene utilisable en thérapie.
FR163M (fr) Nouvelle phénoxy-éthylamine utilisable en thérapeutique.
FR310M (fr) Nouvelle aza-hexylene-imino-éthyl-guanidine utilisable en thérapeutique.
FR1494M (fr) Nouvelle création en thérapeutique.
FR116M (fr) Nouveau dérivé sulfonamidique utilisable en thérapeutique.
BE583856A (fr) Agent opacifiant utilisable en readiologie.